Fluorescence Imaging of Huntingtin mRNA Knockdown

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Huntington's disease (HD) is a genetic neurodegenerative disorder caused by expanded CAG repeats in the HTT gene.
• Mutant huntingtin protein leads to neurotoxicity, and therapies targeting HTT mRNA are under clinical investigation.
• Accurate measurement of HTT mRNA levels is crucial for evaluating the efficacy of knockdown therapies.

Purpose of the Study:

• To develop and validate a fluorescent hybridization imaging agent for quantifying HTT mRNA knockdown in human cells.
• To assess the correlation between this novel imaging method and quantitative PCR (qPCR) for HTT mRNA measurement.

Main Methods:

• Design, synthesis, and characterization of a Cal560-labeled peptide nucleic acid (PNA) conjugated with an IGF1-targeting peptide.
• Testing the PNA-peptide agent in HEK293T cells for HTT mRNA imaging.
• Quantifying HTT mRNA levels using both the fluorescent imaging agent and qPCR after siRNA-mediated knockdown.

Main Results:

• The fluorescent PNA-peptide agent specifically hybridized to human HTT mRNA.
• A strong correlation (Pearson coefficient of 0.865) was observed between fluorescence intensity and qPCR measurements of HTT mRNA levels.
• The imaging method showed a 69 ± 6% reduction in HTT mRNA, consistent with qPCR's 86 ± 5% knockdown by the most effective siRNA.

Conclusions:

• The developed fluorescent hybridization method provides a reliable and potentially real-time alternative to qPCR for assessing HTT mRNA knockdown in HD research.
• This technique holds promise for in vivo imaging and therapeutic monitoring in HD models.